PCSK9 and oropharynx cancer: Further colocalisation analysis for PCSK9 and LDLR showed no conclusive evidence of shared causal variants between LDL-C and oral and oropharyngeal cancer; however, the outcome dataset had a relatively smaller sample size, and typically large sample sizes are required across both traits for better accuracy (S12 Table) [49, 55].